Literature DB >> 19072680

Identifying psychopathic subtypes: combining an empirical personality classification of offenders with the psychopathy checklist-revised.

Ronald Blackburn1, Caroline Logan, John P Donnelly, Stanley J D Renwick.   

Abstract

Mentally disordered offenders who were psychopathic according to the Psychopathy Checklist-Revised (PCL-R) were divided into primary psychopath, secondary psychopath, controlled, and inhibited groups on the basis of a validated empirical classification, using the Antisocial Personality Questionnaire (APQ). They were compared on the factors and facets of the PCL-R, criminal history, Axis I and Axis II psychopathology, experience of child abuse, personality, interpersonal style, and clinical ratings of risk and treatability, to determine the utility of the APQ classification in identifying subtypes of psychopath. Significant differences between APQ primary and secondary psychopaths on several measures support the identification of these groups with the primary and secondary psychopaths hypothesized by Karpman (1948) and others. However, further differences suggest that the controlled and inhibited groups represent additional variants of primary and secondary psychopath, respectively. The results provide further evidence for the heterogeneity of psychopaths, and suggest that the PCL-R encompasses several distinct subtypes of abnormal personality.

Entities:  

Mesh:

Year:  2008        PMID: 19072680     DOI: 10.1521/pedi.2008.22.6.604

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  12 in total

Review 1.  The Development of Severe and Chronic Violence Among Youth: The Role of Psychopathic Traits and Reward Processing.

Authors:  Dennis E Reidy; Elizabeth Krusemark; David S Kosson; Megan C Kearns; Joanne Smith-Darden; Kent A Kiehl
Journal:  Child Psychiatry Hum Dev       Date:  2017-12

2.  Utilitarian moral judgment in psychopathy.

Authors:  Michael Koenigs; Michael Kruepke; Joshua Zeier; Joseph P Newman
Journal:  Soc Cogn Affect Neurosci       Date:  2011-07-18       Impact factor: 3.436

3.  Two subtypes of psychopathic criminals differ in negative affect and history of childhood abuse.

Authors:  Monika Dargis; Michael Koenigs
Journal:  Psychol Trauma       Date:  2017-10-16

4.  Clarifying the factors that undermine behavioral inhibition system functioning in psychopathy.

Authors:  Arielle R Baskin-Sommers; John F Wallace; Donal G MacCoon; John J Curtin; Joseph P Newman
Journal:  Personal Disord       Date:  2010-10

5.  Economic decision-making in psychopathy: a comparison with ventromedial prefrontal lesion patients.

Authors:  Michael Koenigs; Michael Kruepke; Joseph P Newman
Journal:  Neuropsychologia       Date:  2010-04-18       Impact factor: 3.139

6.  Distinct variants of extreme psychopathic individuals in society at large: evidence from a population-based sample.

Authors:  Laura E Drislane; Christopher J Patrick; Andre Sourander; Lauri Sillanmäki; Steven H Aggen; Henrik Elonheimo; Kai Parkkola; Petteri Multimäki; Kenneth S Kendler
Journal:  Personal Disord       Date:  2014-02-10

7.  Trajectories of alcohol and marijuana use among primary versus secondary psychopathy variants within an adjudicated adolescent male sample.

Authors:  Rebecca Waller; Brian M Hicks
Journal:  Personal Disord       Date:  2018-08-06

8.  The clinical profile of high-risk mentally disordered offenders.

Authors:  Jenny Yiend; Mark Freestone; Maria Vazquez-Montes; Josephine Holland; Tom Burns
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-03       Impact factor: 4.328

Review 9.  Person-centered approaches in the study of personality disorders.

Authors:  Brian M Hicks; D Angus Clark; C Emily Durbin
Journal:  Personal Disord       Date:  2017-10

10.  The relationship between five-factor model and diagnostic and statistical manual of mental disorder-fifth edition personality traits on patients with antisocial personality disorder.

Authors:  Mahdi Amini; Abbas Pourshahbaz; Parvaneh Mohammadkhani; Mohammad-Reza Khodaie Ardakani; Mozhgan Lotfi; Mohammad Arash Ramezani
Journal:  J Res Med Sci       Date:  2015-05       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.